Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|21|2199-2207

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.21, 2007-07, pp. : 2199-2207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Metabolic Syndrome

By Fong Tung M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1203-1206

Informa Healthcare

Access to resources Recommend Favorite

The Metabolic Syndrome and Chronic Liver Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5010-5024

Bentham Science Publishers

Access to resources Recommend Favorite

Antiepileptics and the Treatment of Neuropathic Pain: Evidence from Animal Models

By  

Current Pharmaceutical Design, Vol. 11, Iss. 23, 2005-09 ,pp. : 2961-2976

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1623-1646

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Syndrome Components in Murine Models

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 1, 2010-03 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite